/CBDX

CBDX Stock - Curative Biosciences, Inc.

Q: What is the analyst price target for CBDX?

Analyst price target information is not currently available for CBDX.

Q: What is CBDX's market cap?

Market capitalization information is not currently available for CBDX.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CBDX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2016

FY2017

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta64.72

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2017	FY2016
Revenue	N/A	N/A
Gross Profit	$-2,848	$-2,848
Gross Margin	N/A	N/A
Operating Income	$-53,200	$-1,641,160
Net Income	$-53,195	$-1,657,286
Net Margin	N/A	N/A
EPS	$-0.00	$-0.12

Company Overview

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.

Visit Website

Earnings History & Surprises

CBDX

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$N/A

EPS Surprise History

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2018	May 15, 2018	—	—	—	—
Q2 2018	May 15, 2018	—	—	—	—
Q1 2018	Mar 7, 2018	—	—	—	—
Q1 2018	Mar 7, 2018	—	—	—	—

Frequently Asked Questions about CBDX

What is CBDX's current stock price?

Curative Biosciences, Inc. (CBDX) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for CBDX?

No analyst price targets are currently available for this stock.

What sector is Curative Biosciences, Inc. in?

Curative Biosciences, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CBDX's market cap?

Curative Biosciences, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does CBDX pay dividends?

No, Curative Biosciences, Inc. does not currently pay a dividend to shareholders.